Proteomics reveals how proteins drive biology—helping researchers understand disease, uncover biomarkers, and advance precision medicine
Generating genomic data is only the start. Experts meet virtually to solve complex analysis challenges and share insights with their peers
Meet the awardees of Illumina Corporate Foundation’s first IMPACT grants
Multiomics integrates genomic, proteomic, transcriptomic, and other data types to help scientists understand disease and drug response
In Taiwan, Dr. Dau-Ming Niu is using Illumina TruPath Genome to generate new clues for rare disease cases that have long defied diagnosis
| Date | Publication | Title |
|---|---|---|
| 23 Jun 2025 | Endpoints News | Illumina to buy SomaLogic for $350M upfront, pushing further into proteomics |
| 17 Jun 2025 | Forbes | Illumina’s New CIO Brings R&D Mindset As AI Transforms Genomics |
| 13 Jun 2025 | GEN | Proteomics Partnerships Move Multiomics from Theory to Practice |
| 13 Jun 2025 | GEN | Silver Anniversary of the Human Genome Project |
| 12 Jun 2025 | Colorado State University | The pathogen hunter: Next-Generation Sequencing tracks down genetic mutations |
At Illumina, we push boundaries. We think beyond the conventional. We dream big. With the energy of so many bright and accomplished people, the opportunities are endless.
Search for JobsIf you are a member of the media:
If you are not a member of the media, please visit Contact Us.